Cell and Gene Therapy

Game changing gene therapies focus of £14m research hub

Published March. 26. 2024
CGT Banner - Game changing gene therapies

The £14.25m Engineered Genetic Control Systems for Advanced Therapeutics Hub will establish improved gene therapy techniques for patients with serious conditions.

It will create new biological tools to improve the effectiveness and safety of gene therapies, testing them in cancers, cardiovascular disease and rare diseases.

The hub, led by Professor Susan Rosser, will bring together a multidisciplinary team from the Universities of Edinburgh and Oxford, Imperial College London and the CRUK Scotland Institute.

Research hubs

The new centre is one of six announced as part of a £100m UK-wide investment in engineering biology by UK Research and Innovation (UKRI).

Funding for the new hubs is provided by the UKRI Technology Missions Fund, with support from the Biotechnology and Biological Sciences Research Council (BBSRC).

The hubs will be funded for five years and involve multiple academic and industrial partners

https://www.ed.ac.uk/research-innovation/latest-research-news/game-changing-gene-therapies-focus-of-14m-hub

Get the free newsletter

Subscribe to IMAPAC for top news, trends & analysis

Cell and Gene Therapy World Summit Brochure

    Contact Form


    IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

    Download Brochure Sample

      Contact Form


      IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.